Latest Insider Transactions at Anaptysbio, Inc (ANAB)
This section provides a real-time view of insider transactions for Anaptysbio, Inc (ANAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANAPTYSBIO, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANAPTYSBIO, INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 14
2023
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,105
-30.23%
|
$39,995
$19.48 P/Share
|
Sep 14
2023
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+46.28%
|
-
|
Sep 14
2023
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,105
-30.59%
|
$39,995
$19.48 P/Share
|
Sep 14
2023
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+46.58%
|
-
|
Aug 08
2022
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
523
-100.0%
|
$13,075
$25.0 P/Share
|
Jun 08
2022
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,500
-82.7%
|
$60,000
$24.0 P/Share
|
Jun 08
2022
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+45.27%
|
$35,000
$14.02 P/Share
|
May 18
2022
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,146
-68.66%
|
$22,920
$20.5 P/Share
|
May 05
2022
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
668,237
-8.16%
|
$14,032,977
$21.63 P/Share
|
May 05
2022
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
668,237
+8.16%
|
$14,032,977
$21.63 P/Share
|
Mar 21
2022
|
Daniel Faga CEO |
BUY
Grant, award, or other acquisition
|
Direct |
887,043
+50.0%
|
-
|
Dec 20
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
36,645
-13.12%
|
$1,282,575
$35.68 P/Share
|
Dec 20
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,645
+25.83%
|
$36,645
$1.12 P/Share
|
Nov 15
2021
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
964
+50.0%
|
$21,208
$22.03 P/Share
|
Nov 15
2021
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
523
+50.0%
|
$11,506
$22.03 P/Share
|
Nov 15
2021
|
Hamza Suria President, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
964
+1.39%
|
$21,208
$22.03 P/Share
|
Nov 15
2021
|
Paul F. Lizzul Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
964
+50.0%
|
$21,208
$22.03 P/Share
|
Nov 05
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
14,302
-17.45%
|
$500,570
$35.0 P/Share
|
Nov 05
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,302
+14.86%
|
$14,302
$1.12 P/Share
|
Nov 04
2021
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$175,000
$35.0 P/Share
|
Nov 04
2021
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+41.67%
|
$85,000
$17.09 P/Share
|
Nov 04
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
6,059
-8.22%
|
$212,065
$35.0 P/Share
|
Nov 04
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,059
+7.6%
|
$6,059
$1.12 P/Share
|
Nov 01
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
36,646
-18.17%
|
$1,172,672
$32.58 P/Share
|
Nov 01
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,646
+26.0%
|
$36,646
$1.12 P/Share
|
Oct 26
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
15,993
-19.12%
|
$479,790
$30.0 P/Share
|
Oct 26
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,993
+16.05%
|
$15,993
$1.12 P/Share
|
Sep 17
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.88%
|
$10,000
$1.12 P/Share
|
May 12
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+14.79%
|
$10,000
$1.12 P/Share
|
May 04
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
165,000
+2.15%
|
$3,795,000
$23.25 P/Share
|
May 03
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,800
+0.28%
|
$478,400
$23.31 P/Share
|
Apr 30
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
35,700
+0.48%
|
$821,100
$23.16 P/Share
|
Apr 27
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
33,800
+0.46%
|
$777,400
$23.82 P/Share
|
Apr 26
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,900
+0.19%
|
$319,700
$23.8 P/Share
|
Apr 23
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
99,600
+1.36%
|
$2,290,800
$23.54 P/Share
|
Mar 09
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
531,000
+6.91%
|
$9,558,000
$18.7 P/Share
|
Mar 08
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,777,800
+29.56%
|
$50,000,400
$18.97 P/Share
|
Feb 23
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
29,500
+0.76%
|
$737,500
$25.48 P/Share
|
Nov 16
2020
|
James N Topper Director |
BUY
Other acquisition or disposition
|
Direct |
48,958
+26.96%
|
-
|
Nov 16
2020
|
James N Topper Director |
SELL
Other acquisition or disposition
|
Indirect |
1,416,747
-55.33%
|
-
|